Alternative Splicing Controls Myotonic Dystrophy Protein Kinase Structure, Enzymatic Activity, and Subcellular Localization

REFERENCES

• Alessi, D. R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B. A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15: 6541–6551.
   PubMed Web of Science ®Google Scholar
• Alessi, D. R., F. B. Caudwell, M. Andjelkovic, B. A. Hemmings, and P. Cohen. 1996. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399: 333–338.
   PubMed Web of Science ®Google Scholar
• Amano, M., K. Chihara, N. Nakamura, T. Kaneko, Y. Matsuura, and K. Kaibuchi. 1999. The COOH terminus of Rho-kinase negatively regulates Rho-kinase activity. J. Biol. Chem. 274: 32418–32424.
   PubMed Web of Science ®Google Scholar
• Amano, M., Y. Fukata, and K. Kaibuchi. 2000. Regulation and functions of Rho-associated kinase. Exp. Cell Res. 261: 44–51.
   PubMed Web of Science ®Google Scholar
• Benders, A. G. M., P. J. T. A. Groenen, F. T. J. J. Oerlemans, J. H. Veerkamp, and B. Wieringa. 1997. Myotonic dystrophy protein kinase is involved in the modulation of the Ca2+ homeostasis in skeletal muscle cells. J. Clin. Investig. 100: 1440–1447.
   PubMedGoogle Scholar
• Berul, C. I., C. T. Maguire, M. J. Aronovitz, J. Greenwood, C. Miller, J. Gehrmann, D. Housman, M. E. Mendelsohn, and S. Reddy. 1999. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J. Clin. Investig. 103: R1–R7.
   PubMedGoogle Scholar
• Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248–254.
   PubMed Web of Science ®Google Scholar
• Brazil, D. P., and B. A. Hemmings. 2001. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26: 657–664.
   PubMed Web of Science ®Google Scholar
• Brodbeck, D., M. M. Hill, and B. A. Hemmings. 2001. Two splice variants of protein kinase Bγ have different regulatory capacity depending on the presence or absence of the regulatory phosphorylation site serine 472 in the carboxy-terminal hydrophobic domain. J. Biol. Chem. 276: 29550–29558.
   PubMedGoogle Scholar
• Brook, J. D., M. E. McCurrach, H. G. Harley, A. J. Buckler, D. Church, H. Aburatani, K. Hunter, V. P. Stanton, J.-P. Thirion, T. Hudson, R. Sohn, B. Zemelman, R. G. Snell, S. A. Rundle, S. Crow, J. Davies, P. Shelbourne, J. Buxton, C. Jones, V. Juvonen, K. Johnson, P. S. Harper, D. J. Shaw, and D. E. Housman. 1992. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68: 799–808.
   PubMed Web of Science ®Google Scholar
• Burgess, H. A., and O. Reiner. 2002. Alternative splice variants of doublecortin-like kinase are differentially expressed and have different kinase activities. J. Biol. Chem. 277: 17696–17705.
   PubMedGoogle Scholar
• Bush, E. W., S. M. Helmke, R. A. Birnbaum, and M. B. Perryman. 2000. Myotonic dystrophy protein kinase domains mediate localization, oligomerization, novel catalytic activity, and autoinhibition. Biochemistry 39: 8480–8490.
   PubMedGoogle Scholar
• Caceres, J. F., and A. R. Kornblihtt. 2002. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet. 18: 186–193.
   PubMed Web of Science ®Google Scholar
• Chalfant, C. E., H. Mischak, J. E. Watson, B. C. Winkler, J. Goodnight, R. V. Farese, and D. R. Cooper. 1995. Regulation of alternative splicing of protein kinase C beta by insulin. J. Biol. Chem. 270: 13326–13332.
   PubMedGoogle Scholar
• Charlet-B., N., R. S. Savkur, G. Singh, A. V. Philips, E. A. Grice, and T. A. Cooper. 2002. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 10: 45–53.
   PubMed Web of Science ®Google Scholar
• Davis, B. M., M. E. McCurrach, K. L. Taneja, R. H. Singer, and D. E. Housman. 1997. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. USA 94: 7388–7393.
   PubMed Web of Science ®Google Scholar
• Di Cunto, F., E. Calautti, J. Hsiao, L. Ong, G. Topley, E. Turco, and G. P. Dotto. 1998. Citron Rho-interacting kinase, a novel tissue-specific ser/thr kinase encompassing the Rho-Rac-binding protein Citron. J. Biol. Chem. 273: 29706–29711.
   PubMedGoogle Scholar
• Dunne, P. W., E. T. Walch, and H. F. Epstein. 1994. Phosphorylation reactions of recombinant human myotonic dystrophy protein kinase and their inhibition. Biochemistry. 33: 10809–10814.
   PubMedGoogle Scholar
• Feng, J., M. Ito, K. Ichikawa, N. Isaka, M. Nishikawa, D. J. Hartshorne, and T. Nakano. 1999. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J. Biol. Chem. 274: 37385–37390.
   PubMed Web of Science ®Google Scholar
• Fu, Y.-H., A. Pizzuti, R. G. Fenwick Jr., J. King, S. Rajnarayan, P. W. Dunne, J. Dubel, G. A. Nasser, T. Ashizawa, P. de Jong, B. Wieringa, R. G. Korneluk, M. B. Perryman, H. F. Epstein, and C. T. Caskey. 1992. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255: 1256–1258.
   PubMed Web of Science ®Google Scholar
• Groenen, P., and B. Wieringa. 1998. Expanding complexity in myotonic dystrophy. BioEssays 20: 901–912.
   PubMed Web of Science ®Google Scholar
• Groenen, P. J. T. A., D. G. Wansink, M. Coerwinkel, W. van den Broek, G. Jansen, and B. Wieringa. 2000. Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties. Hum. Mol. Genet. 9: 605–616.
   PubMedGoogle Scholar
• Harper, P. S. 2001. Myotonic dystrophy, 3rd ed., vol. 37. W. B. Saunders, London, United Kingdom.
   Google Scholar
• Hill, M. M., and B. A. Hemmings. 2002. Analysis of protein kinase B/Akt. Methods Enzymol. 345: 448–463.
   PubMedGoogle Scholar
• Jansen, G., P. J. Groenen, D. Bachner, P. H. Jap, M. Coerwinkel, F. Oerlemans, W. van den Broek, B. Gohlsch, D. Pette, J. J. Plomp, P. C. Molenaar, M. G. Nederhoff, C. J. van Echteld, M. Dekker, A. Berns, H. Hameister, and B. Wieringa. 1996. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat. Genet. 13: 316–324.
   PubMedGoogle Scholar
• Justice, R. W., O. Zilian, D. F. Woods, M. Noll, and P. J. Bryant. 1995. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 9: 534–546.
   PubMed Web of Science ®Google Scholar
• Kawano, Y., Y. Fukata, N. Oshiro, M. Amano, T. Nakamura, M. Ito, F. Matsumura, M. Inagaki, and K. Kaibuchi. 1999. Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J. Cell Biol. 147: 1023–1038.
   PubMed Web of Science ®Google Scholar
• Leung, T., X.-Q. Chen, I. Tan, E. Manser, and L. Lim. 1998. Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42 effector in promoting cytoskeletal reorganization. Mol. Cell. Biol. 18: 130–140.
   PubMedGoogle Scholar
• Mahadevan, M., C. Amemiya, G. Jansen, L. Sabourin, S. Baird, C. Neville, N. Wormskamp, B. Segers, M. Batzer, J. Lamerdin, P. de Jong, B. Wieringa, and R. Korneluk. 1993. Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene. Hum. Mol. Genet. 2: 299–304.
   PubMed Web of Science ®Google Scholar
• Mankodi, A., M. P. Takahashi, H. Jiang, C. L. Beck, W. J. Bowers, R. T. Moxley, S. C. Cannon, and C. A. Thornton. 2002. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10: 35–44.
   PubMed Web of Science ®Google Scholar
• Manning, G., G. D. Plowman, T. Hunter, and S. Sudarsanam. 2002. Evolution of protein kinase signaling from yeast to man. Trends Biochem. Sci. 27: 514–520.
   PubMed Web of Science ®Google Scholar
• Millward, T., P. Cron, and B. A. Hemmings. 1995. Molecular cloning and characterization of a conserved nuclear serine(threonine) protein kinase. Proc. Natl. Acad. Sci. 92: 5022–5026.
   PubMedGoogle Scholar
• Millward, T. A., C. W. Heizmann, B. W. Schafer, and B. A. Hemmings. 1998. Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J. 17: 5913–5922.
   PubMedGoogle Scholar
• Millward, T. A., D. Hess, and B. A. Hemmings. 1999. Ndr protein kinase is regulated by phosphorylation on two conserved sequence motifs. J. Biol. Chem. 274: 33847–33850.
   PubMedGoogle Scholar
• Mounsey, J. P., D. J. Mistry, C. W. Ai, S. Reddy, and J. R. Moorman. 2000. Skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase. Hum. Mol. Genet. 9: 2313–2320.
   PubMedGoogle Scholar
• Mounsey, J. P., P. Xu, J. E. John, 3rd, L. T. Horne, J. Gilbert, A. D. Roses, and J. R. Moorman. 1995. Modulation of skeletal muscle sodium channels by human myotonin protein kinase. J. Clin. Investig. 95: 2379–2384.
   PubMedGoogle Scholar
• Muranyi, A., R. Zhang, F. Liu, K. Hirano, M. Ito, H. F. Epstein, and D. J. Hartshorne. 2001. Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity. FEBS Lett. 493: 80–84.
   PubMedGoogle Scholar
• Nissim-Rafinia, M., and B. Kerem. 2002. Splicing regulation as a potential genetic modifier. Trends Genet. 18: 123–127.
   PubMed Web of Science ®Google Scholar
• Obata, T., M. B. Yaffe, G. G. Leparc, E. T. Piro, H. Maegawa, A. Kashiwagi, R. Kikkawa, and L. C. Cantley. 2000. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J. Biol. Chem. 275: 36108–36115.
   PubMed Web of Science ®Google Scholar
• Philips, A. V., L. T. Timchenko, and T. A. Cooper. 1998. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280: 737–740.
   PubMed Web of Science ®Google Scholar
• Ranum, L. P. W., and J. W. Day. 2002. Dominantly inherited, non-coding microsatellite expansion disorders. Curr. Opin. Genet. Dev. 12: 266–271.
   PubMed Web of Science ®Google Scholar
• Reddy, S., D. B. J. Smith, M. M. Rich, J. M. Leferovich, P. Reilly, B. M. Davis, K. Tran, H. Rayburn, R. Bronson, D. Cros, R. J. Balice-Gordon, and D. Housman. 1996. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat. Genet. 13: 325–335.
   PubMedGoogle Scholar
• Savkur, R. S., A. Philips, and T. A. Cooper. 2001. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29: 40–47.
   PubMed Web of Science ®Google Scholar
• Scorrano, L., S. A. Oakes, J. T. Opferman, E. H. Cheng, M. D. Sorcinelli, T. Pozzan, and S. J. Korsmeyer. 2003. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300: 135–139.
   PubMed Web of Science ®Google Scholar
• Sergeant, N., B. Sablonniere, S. Schraen-Maschke, A. Ghestem, C. Maurage, A. Wattez, P. Vermersch, and A. Delacourte. 2001. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 10: 2143–2155.
   PubMed Web of Science ®Google Scholar
• Seto, M., Y. Sasaki, and Y. Sasaki. 1990. Alteration in the myosin phosphorylation pattern of smooth muscle by phorbol ester. Am. J. Physiol. 259: C769–C774.
   PubMedGoogle Scholar
• Stadhouders, A. M., P. H. Jap, H. P. Winkler, H. M. Eppenberger, and T. Wallimann. 1994. Mitochondrial creatine kinase: a major constituent of pathological inclusions seen in mitochondrial myopathies. Proc. Natl. Acad. Sci. USA 91: 5089–5093.
   PubMed Web of Science ®Google Scholar
• Tan, I., K. T. Seow, L. Lim, and T. Leung. 2001. Intermolecular and intramolecular interactions regulate catalytic activity of myotonic dystrophy kinase-related Cdc42-binding kinase α. Mol. Cell. Biol. 21: 2767–2778.
   PubMed Web of Science ®Google Scholar
• Timchenko, L., N. W., T. Schneider, B. Patel, F. Hofmann, and C. T. Caskey. 1995. Full-length myotonin protein kinase (72 kDa) displays serine kinase activity. Proc. Natl. Acad. Sci. USA 92: 5366–5370.
   PubMedGoogle Scholar
• Tiscornia, G., and M. S. Mahadevan. 2000. Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. Mol. Cell 5: 959–967.
   PubMedGoogle Scholar
• Turner, M. S., L. Fen Fen, J. W. Trauger, J. Stephens, and P. LoGrasso. 2002. Characterization and purification of truncated human Rho-kinase II expressed in Sf-21 cells. Arch. Biochem. Biophys. 405: 13–20.
   PubMed Web of Science ®Google Scholar
• Ueda, H., S. Ohno, and T. Kobayashi. 2000. Myotonic dystrophy and myotonic dystrophy protein kinase. Progr. Histochem. Cytochem. 35: 187–251.
   PubMedGoogle Scholar
• Wansink, D. G., and B. Wieringa. Transgenic mouse models for myotonic dystrophy type 1 (DM1). Cytogenet. Genome Res., in press.
   Google Scholar
• Waring, J. D., R. Haq, K. Tamai, L. A. Sabourin, J.-E. Ikeda, and R. G. Korneluk. 1996. Investigation of myotonic dystrophy kinase isoform translocation and membrane association. J. Biol. Chem. 271: 15187–15193.
   PubMedGoogle Scholar
• Xu, T., W. Wang, S. Zhang, R. A. Stewart, and W. Yu. 1995. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 121: 1053–1063.
   PubMed Web of Science ®Google Scholar
• Yang, J., P. Cron, V. Thompson, V. Good, D. Hess, B. Hemmings, and D. Barford. 2002. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell 9: 1227–1240.
   PubMed Web of Science ®Google Scholar